Our lab observed increased STAT1 expression in human mammary adenocarcinoma in the presence of nuclear EGFR, which synergized with co-expression of STAT3 to further enhance STAT1 levels [85]. The gene discussed is STAT3; the disease is breast adenocarcinoma.